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ABSTRAK 
 
Stres oksidatif dikaitkan dengan osteoporosis pos-menopaus yang meningkatkan ri-
siko patah tulang. Tokotrienol sawit ialah antioksidan yang poten dan berpotensi untuk 
digunakan bagi merawat osteoporosis pos-menopaus. Tujuan kajian ialah untuk me-
nentukan samada suplementasi tokotrienol sawit boleh mengurangkan stress oksidatif 
dan meningkatkan kekuatan tulang pada model tikus terovariektomi. Tikus dibahagi-
kan kepada empat kumpulan : (i) bedah sham (SHAM) (ii) kawalan ovariektomi (OVX) 
(iii) ovariektomi dan diberi 60mg/kg α-tokoferol melalui gavaj oral (OVX+ATF) (iv) ova-
riektomi dan diberi 60mg/kg tokotrienol sawit melalui gavaj oral (OVX+PTT). Selepas 
rawatan selama lapan bulan, sampel darah diambil untuk mengukur status oksidatif 
(MDA, SOD dan GPX) sementara tulang femur diuji kekuatan dan resistan biomeka-
nikal terhadap kepatahan. Ovariektomi menyebabkan stres oksidatif seperti yang di-
tunjukkan dengan peningkatan aras MDA dan penurunan aras aktiviti GPX. Tokotrie-
nol sawit menunjukkan perlindungan terhadap stres oksidatif aruhan ovariektomi se-
perti yang ditunjukkan dengan penurunan aras MDA dan peningkatan aktiviti GPX dan 
SOD pada kumpulan OVX+PTT. Apabila dibandingkan, α-tokoferol hanya berupaya 
meningkatkan SOD tetapi tidak setinggi tokotrienol sawit. Ujian biomekanikal menun-
jukkan bahawa ovariektomi tidak memberi kesan signifikan kepada kekuatan tulang 
selepas rawatan selama lapan minggu. Suplementasi tokotrienol sawit selama lapan 
minggu berkesan untuk mencegah stres oksidatif pada tikus pos-menopaus.  
 
Kata kunci:  vitmain E, tikus terovariektomi, osteoporosis, histomorfometri tulang, 
biomekanikal 
 
 
ABSTRACT  
 
Oxidative stress has been associated with postmenopausal osteoporosis which pre-
disposes to risk of fracture. Palm tocotrienol is a potent antioxidant and has the poten-
tial to be used for treatment of post-menopausal osteoporosis. The aim of the study is 
to determine if palm tocotrienol supplementation could alleviate oxidative stress in 
ovariectomised rat model and improve its bone strength. The rats were di-
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vided into four groups: (i) sham-operated group (SHAM) (ii) ovariectomised-control 
group (OVX) (iii) ovariectomised and given 60mg/kg α-tocopherol by oral gavage (OVX 
+ ATF) (iv) ovariectomised and given 60mg/kg palm tocotrienols by oral gavage (OVX 
+ PTT). After eight weeks of treatment, blood samples were taken to measure oxida-
tive status (MDA, SOD and GPX) while the femurs were biomechanically tested for 
strength and resistance to fracture. Ovariectomy was shown to induce oxidative stress 
as shown by the raised MDA levels and reduced GPX activity. Palm tocotrienols 
seemed to offer protection against the ovariectomy-induced oxidative stress as shown 
by the suppression of MDA levels and raised GPX and SOD activities in the OVX+PTT 
group. In comparison, α-tocopherol was only able to raise the SOD but not as high as 
palm tocotrienols. The biomechanical tests have shown that ovariectomy has not af-
fected the bone strength significantly after eight weeks. Palm tocotrienols supplemen-
tation for eight weeks was effective in preventing oxidative stress in a post-meno-
pausal rat.  
 
Key words:  vitamin E, ovariectomised-rats, osteoporosis, bone histomorphometry, 
biomechanical 
  
 
 
INTRODUCTION  
 
Osteoporosis is a condition of decreased 
bone mass which leads to fragile bones 
with increased risk of fractures. It has 
affected 75 million people in Europe, 
USA and Japan (EFFO & NOF 1997). 
One in 3 women and 1 in 5 men over 50 
years old will experience osteoporotic 
fractures (Melton et al. 1998, Kanis et al. 
2000, Randell et al. 1995, Gullberg et al. 
1997). It is projected that more than 50% 
of all osteoporotic hip fractures will occur 
in Asia by the year 2050 (Cooper et al. 
1992). Post menopausal osteoporosis, 
which occurs in estrogen-deficient wo-
men, is the commonest form of osteo-
porosis. There is increasing evidence 
that oxidative stress may be partly res-
ponsible for post-menopausal osteoporo-
sis. Estrogen itself is an antioxidant with 
radical-scavenging properties and its de-
ficiency has been associated with oxida-
tive stress (Dubey et al. 2000). Oxidative 
stress has been shown to stimulate os-
teoclast differentiation and function 
(Garrett et al. 1990) and inhibit osteoblast 
differentiation (Bai et al. 2004). Ferric 
nitrilotiracetate, an oxidizing agent which 
causes oxidative stress was shown to 
reduce bone calcium content in young 
growing rats (Yee & Ima Nirwana 1998), 
increase osteoclast numbers and reduce 
bone volume and thickness (Ahmad et al. 
2005). 
Many human studies have linked oxi-
dative stress to osteoporosis. In subjects 
with osteoporosis, the malondialdehyde 
(MDA) levels were increased while the 
antioxidant enzymes, superoxide dismu-
tase and glutathion peroxidase were re-
duced compared to the control group 
(Sontakke et al. 2002). While in another 
recent study, osteoporotic women were 
found to have high MDA levels and low 
catalase and gluthatione peroxidase ac-
tivities (Ozgocmen et al. 2007). Elderly 
women with osteoporosis were found to 
have lower endogenous and exogenous 
anti-oxidants (Maggio et al. 2003). A 
population based study found an associ-
ation between the increases of prostag-
landin F2α, a bio-marker of oxidative 
stress to reduction in bone mineral den-
sity (Basu et al. 2001). 
With all the evidence pointing to the in
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volvement of oxidative stress in osteopo-
rosis, studies on the ability of potent anti-
oxidants like vitamin E to protect bone 
from osteoporosis in estrogen deficient 
women need to be carried out. It is also 
important to determine if the benefit of 
vitamin E intake would extend to better 
bone strength in order to reduce the risk 
of osteoporotic fracture. A biomechanical 
test is a useful tool to evaluate bone 
strength which is associated with sus-
ceptibility to fracture. It can only be car-
ried out in animal models as bone sam-
ples need to be subjected to force until 
they break to get the accurate result. 
Previous studies have used the rat as a 
standard rodent model for bone biome-
chanical studies (Ferretti et al. 1993, 
Kimmel 1996, Peng et al. 1994, Raab et 
al. 1990, Tuukkanen et al. 1994).  
Vitamin E is a fat soluble vitamin with a 
chain–breaking ability. There are two 
forms of vitamin E, tocopherol and toco-
trienol which can be further subdivided 
into α, β, γ and δ . Tocotrienol is a unique 
vitamin E which is abundant in palm oil of 
Elaeis guineensis species. Tocotrienol 
has better antioxidant ability compared to 
tocopherol because of its higher recycling 
efficacy (Serbinova et al. 1991, Kamat et 
al. 1997). Vitamin E is thought to protect 
bone via its antioxidant properties by 
helping the internal anti-oxidative de-
fense against free-radicals and sca-
venging the lipid peroxidation radicals, 
therefore preventing oxidative stress.  
The aim of the study is to determine 
the protective effects of palm tocotrienol 
on the oxidative status and bone bio-me-
chanical strength of rat model at eight 
weeks post-ovariectomy.  
 
METHODS 
 
Sixty-four female Wistar rats aged three 
months, weighing between 200-250 
grams were housed in groups of three at 
27°C with 12:12 hour light-dark cycle. 
The rats were fed ‘rat chow’ Gold Coin 
(Port Klang, Malaysia) and drinking water 
made available ad libitum. 
There were eight rats in each group 
and they received the following treat-
ments: Group 1(Sham) rats were sham-
operated. Group 2 (OVXC) rats were 
ovariectomised and given vehicle (olive 
oil) orally. Group 3 (OVX+ATF) rats were 
ovariectomised and given 60 mg/kg rat 
weight of α-tocopherol orally. Group 4 
(OVX+PTT) rats were ovariectomised 
and given 60 mg/kg rat weight of palm 
tocotrienols orally.  
Alpha-tocopherol acetate (Sigma, St. 
Louis, MO, USA) or palm tocotrienol 
mixture (Palm Oil Research Institute of 
Malaysia (PORIM) was diluted in olive oil 
( Bertolli, Lucca, Italy) to obtain a con-
centration of 60 mg/kg rat weight, each in 
0.1 ml volume. The diluted vitamin E was 
given orally to rats using gavage needle 
6 days / week for three weeks. The palm 
tocotrienols has the following composi-
tion: α-tocotrienol (30.7%), γ-tocotrienol 
(55.2%) and δ-tocotrienol (14.1%). Olive 
oil was chosen as the diluents because it 
contains only 0.0051 % α-tocopherol and 
no tocotrienols. 
Rats were bilaterally ovariectomised 
using dorsal approach under anaesthe-
sia. For sham-operated rats, the ovaries 
were identified but left intact. The rats 
were allowed to recover for two weeks 
before treatment was started. 
Blood samples were collected into an 
EDTA tube from the retro-orbital vein of 
the anesthetized rats. The blood was 
centrifuged at 3000 rpm at 4°C for 10 
minutes and the plasma was stored at -
70°C. The erythrocytes were washed 
with normal saline, centrifuged at 3000 
rpm for 10 minutes and stored at -20°C. 
The left femurs were cleaned, wrapped in 
gauze soaked with phosphate-buffered 
solution and aluminum foil and stored at -
70°C.  
The plasma malondialdehyde (MDA) 
levels were measured according to the 
method of Ledwozyw et al. (Ledwozyew 
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et al. 1986). The MDA reacts with thi-
obarbituric acid (TBARS) to form a pin-
kish complex which was measured using 
a spectrophotometer (Shimadzu UV-
160A, Kyoto, Japan) at a wavelength of 
515 nm. The total protein in the plasma is 
measured according to the method of 
Lowry et al. (1951). The MDA value 
(nmol) is divided with the total protein in 
plasma (mg). The plasma glutathione 
peroxidase (GPX) and erythrocyte supe-
roxide dismutase (SOD) activities were 
measured by using RANSEL and 
RANSOD kits (RANDOX Lab Ltd, Co 
Antrim, UK) respectively.  
The femurs were thawed at room tem-
perature one hour before the start of the 
biomechanical test. The femurs were 
subjected to three point bending configu-
ration using an Instron® machine 5560 
and were analysed using Bluehill® 2 soft-
ware (High Wycombe, UK). The data 
obtained were used to plot load versus 
displacement and stress versus strain 
graphs. Bone stiffness and Young’s 
Modulus were then derived from the 
graphs.  
The results were expressed as mean 
values ±S.E.M. Data analysis was per-
formed using Statistical Package for So-
cial Sciences (SPSS 12.0.1, Chicago, IL, 
USA) software. Statistical test used was 
ANOVA followed by Tukey’s hsd for nor-
mally distributed data and Kruskal-Wallis 
and Mann-Whitney test for data that was 
not normally distributed. The results were 
presented as mean values ± standard 
error of the mean (SEM). This study was 
approved by the Universiti Kebangsaan 
Malaysia Animal Ethics Committee 
(UKMAEC).   
 
RESULTS 
 
There was a significantly higher level of 
MDA in the OVXC group compared to the 
Sham and OVX+PTT groups (Figure 1). 
This indicated that ovariectomy has led to 
an increase in lipid peroxidation activity. 
However, oral supplementation with palm 
tocotrienols at 60mg/kg was able to re-
duce the lipid peroxidation activity in the 
ovariectomised rats.   
 After treatment, the SOD levels of the 
OVXC group remained unchanged from 
the Sham group but were significantly 
lower than the OVX+ATF and OVX+PTT 
groups. Ovariectomy did not affect SOD 
levels but oral supplementation of 
60mg/kg of α-tocopherol or palm toco-
trienols raised the SOD. The OVX+PTT 
group had higher levels of SOD com-
pared to the OVX+ATF group (Figure 2). 
After treatment, the GPX levels of the 
OVXC group were significantly lower 
than the Sham and OVX+PTT groups. 
These results showed that ovariectomy 
had reduced the GPX level but oral sup-
plementation with palm tocotrienols pre-
vented the reduction in the GPX level 
(Figure 3). 
As for the biomechanical parameters, a 
pattern was seen although not significant, 
whereby ovariectomy had weakened the 
femur ability to withstand load and stress,  
 
 
 
 
 
 
 
 
 
 
 
Same alphabet indicates significant difference 
between the groups. *indicates significant 
difference before and after treatment within the 
same group. Significance is taken at p<0.05. 
Sham  : sham-operated 
OVX  : ovariectomised and given vehicle (olive 
oil) 
OVX+ATF: ovariectomised and 60mg/kg body 
weight of α-tocopherol 
OVX+PTT: ovariectomised and 60mg/kg body 
weight of palm tocotrienols. 
 
Figure 1: The plasma malondialdehyde (MDA) 
levels for all the groups before and after treatment. 
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 but all these were improved with vitamin 
E supplementations. Vitamin E supple-
mentations had also improved femur 
stiffness and Young’s modulus value 
(Table 1). 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
The current treatments for post-meno-
pausal osteoporosis are estrogen re-
placement therapy, raloxifene, bisphos-
phonates and calcitonin. Alternative 
treatments using herbs and natural prod-
ucts have been suggested such as 
Rehmania glutinosa, royal jelly, 
sumbucus williamsii HANCE, chondroitin 
sulfate and fructo-oligosaccharides (Oh 
et al. 2003, Ha 2004, Devareddy et al. 
2006, Xie et al 2005, Hidoka et al. 2006). 
Several studies have also shown the 
potential of certain vitamins as alternative 
treatments for osteoporosis. High doses 
of vitamin K2 could partially prevent the 
bone loss in orchidectomised young rats 
by normalizing the raised bone resorption 
(Iwamato et al. 2003). An analogue of 
vitamin D3 has been shown to promote 
bone growth in ovariectomised rats and 
cultured osteoblast (Shevde et al. 2002). 
Vitamin E especially palm tocotrienols 
were able to protect rat bones against the 
deleterious effects of ovariectomy 
(Norazlina et al. 2000), orchidectomy 
(Ima Nirwana et al. 2000), ferric-nitrilo-
triacetate (Ahmad et al. 2005) and nico-
tine (Hermizi et al. 2007).  
Same alphabet indicates significant difference 
between the groups. *indicates significant 
difference before and after treatment within the 
same group. Significance is taken at p<0.05. 
Sham  : sham-operated 
OVX  : ovariectomised and given vehicle (olive 
oil) 
OVX+ATF: ovariectomised and 60mg/kg body 
weight of α-tocopherol 
OVX+PTT: ovariectomised and 60mg/kg body 
weight of palm tocotrienols. 
 
Figure 2: The erythrocyte superoxide dismutase 
levels for all the groups before and after treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
Same alphabet indicates significant difference 
between the groups. *indicates significant 
difference before and after treatment within the 
same group. Significance is taken at p<0.05. 
Our previous study (unpublished) has 
confirmed that osteoporotic changes 
were detected histologically as early as 
four weeks post-ovariectomy in the rat 
model. In the present study we found that 
after eight weeks of treatment, ovariec-
tomised-rats have increased oxidative 
stress compared to the sham-operated 
rats. This was shown by the increase in 
the lipid peroxidation product, MDA and 
the decrease in the antioxidant enzyme 
glutathione peroxidase (GPX). There also 
appeared to be a decrease in the super-
Sham  : sham-operated 
OVX  : ovariectomised and given vehicle (olive 
oil) 
OVX+ATF: ovariectomised and 60mg/kg body 
weight of α-tocopherol 
OVX+PTT: ovariectomised and 60mg/kg body 
weight of palm tocotrienols. 
 
Figure 3: The plasma glutathione peroxidase level 
before and after treatment. 
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Table 1: The rat femur bone biomechanical parameters for all the groups after treatment. 
 
Group Maximum load 
(N) 
Maximum 
Stress (MPa) 
Stiffness 
(N/mm) 
Young’s 
modulus (E) 
Sham 117.89±12.01 166.78±11.23 175.23±18.02 57.94±14.91 
OVX 107.5±4.20 148.68±8.02 195.7±12.81 67.56±8.85 
OVX+ATF 117.83±8.05 170.12±9.85 253.41±8.02 78.38±6.43 
OVX + PTT 108.14±3.43 155.47±7.21 243.55±8.32 83.07±12.04 
oxide dismutase (SOD) levels but the 
changes were not significant. Among the 
reactive oxygen species, hydrogen pe-
roxide is the most prominent free radicals 
as it can readily pass through cell mem-
branes and cannot be excluded from 
cells. SOD converts superoxide to hydro-
gen peroxide (H2O2) which is then con-
verted by GPX to water. 
GPX also degrade H2O2 that originates 
from the oxidation of polyunsaturated 
fatty acids (Puglia & Powell 1984). 
Therefore, the reduction in GPX level 
would be more significant as it is actively 
involved in converting H2O2 to water. 
Muthusami et al. (2005) was able to 
demonstrate that ovariectomy had re-
duced both SOD and GPX activities. 
However, these anti-oxidant enzymes 
were measured in the bone, where-as we 
have measured the SOD level in the 
plasma. Estrogen deficiency in postme-
nopausal women leads to oxidative 
stress as shown by a decrease in thiol 
antioxidants, exposing the bone to oxida-
tive damage (Lean et al. 2003). Lean et 
al. (2005) has found that the antioxidants, 
N-acetyl-cysteine and ascorbate were as 
effective as estrogen in normalizing the 
glutathione and thioredoxin reductase 
activities in rodents in order to prevent 
ovariectomy-induced bone loss. We have 
shown in this study that vitamin E, a po-
tent antioxidant, has demonstrated a 
similar protective role against ovariec-
tomy-induced oxidative stress by sup-
pressing MDA levels and raising GPX 
and SOD activities. Palm tocotrienols 
were clearly the better vitamin E in pro-
tecting the bones against oxidative dam-
age post-ovariectomy. As previously 
shown, α-tocotrienol has better anti-
oxidant activity than α-tocopherol 
(Serbinova et al. 1991, Suzuki et al. 
1993). The superior antioxidant activity of 
tocotrienols may be contributed by its 
more uniform distribution in the mem-
brane lipid bilayer, more efficient interac-
tion of the chromanol ring with lipid radi-
cals and higher recycling efficiency from 
chromanoxyl radicals (Serbinova et al. 
1991).  
In the present study, palm-tocotrienols 
were able to prevent lipid peroxidation in 
ovariectomised rats. Both α-tocopherol 
and palm tocotrienols were found to raise 
the SOD level with the latter having a 
more profound effect. While for the GPX 
level, only palm tocotrienols were able to 
restore the GPX level of ovariectomised 
rats back to the sham-operated level. 
These results have demonstrated the 
ability of vitamin E to reactivate the anti-
oxidant enzymes and guard against insult 
caused by oxidative stress.  
Based on our previous study (unpub-
lished) that the femur should be osteopo-
rotic as early as four weeks post-ova-
riectomy, we have assessed the bone 
strength by running a biomechanical test. 
In the present study, patterns of reduced 
bone strength in all the biomechanical 
parameters were seen in the ovariecto-
mised–control rats. However, even after 
eight weeks post-ovariectomy, they were 
not sufficiently low enough to record any 
significant difference. A study by Xie et 
al. (Xie et al. 2005), demonstrated signifi-
cant reduction in the biomechanical pa-
rameters in rats sixteen weeks post-ova-
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riectomy. Therefore, we conclude that 
osteoporosis at eight weeks post-ova-
riectomy was not severe enough to affect 
biomechanical properties although os-
teoporosis should have set in four weeks 
earlier. The different strain of rats used in 
the study by Xie et al. (Xie et al. 2005), 
which had used Sprague-Dawley com-
pared to Wistar in our study may have 
also accounted for the difference in the 
findings. 
In conclusion, palm tocotrienols given 
as oral supplementation at 60 mg/kg 
were able to prevent the oxidative stress 
induced by ovariectomy in a rat model. 
The efficacy of palm tocotrienols was 
greater than α-tocopherol. Palm tocotrie-
nols have the potential to be used for the 
treatment and prevention of post-meno-
pausal osteoporosis. A longer post-ova-
riectomy period is required to assess the 
ability of vitamin E in improving the bone 
biomechanical strength in the post-me-
nopausal rat model.  
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